Warning
Ajanta Pharma USA Inc Recalls Fenofibrate Capsules
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0611-2026Drug / Pharmaceutical
Ajanta Pharma USA Inc Recalls Fenofibrate Capsules
Ajanta Pharma USA Inc · Class II — Moderate Risk
Product Description
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Reason for Recall
CGMP Deviations
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Ajanta Pharma USA Inc has recalled a pharmaceutical product that the FDA classified as Class II affecting 3648 bottles. The recall was initiated on May 28, 2026. CGMP Deviations. It was distributed in U.S. Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.